Matrilysins and stromelysins in pathogenesis and diagnostics of cancers

BM Piskór, A Przylipiak, E Dąbrowska… - Cancer management …, 2020 - Taylor & Francis
Matrix metalloproteinases (MMPs) are endopeptidases which are widely studied in terms of
their role in the physiological and pathological processes in the organism. In this article, we …

[HTML][HTML] Plasma concentrations of matrilysins MMP-7 and MMP-26 as diagnostic biomarkers in breast cancer

BM Piskor, A Przylipiak, E Dąbrowska… - Journal of Clinical …, 2021 - mdpi.com
Metalloproteinases (MMPs) are a group of proteolytic enzymes involved in the maintenance
of a proper structure of extracellular matrix (ECM). Matrilysins (MMP-7 and MMP-26) are …

Plasma levels and tissue expression of selected cytokines, metalloproteinases and tissue inhibitors in patients with cervical cancer

I Sidorkiewicz, B PiskÓR, E DĄBrowska… - Anticancer …, 2019 - ar.iiarjournals.org
Background: Cytokines, metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) take
part in many processes involved in tumor progression and invasion such as degradation of …

Possible diagnostic application of CXCL12 and CXCR4 as tumor markers in breast cancer patients

E Dąbrowska, A Przylipiak, M Zajkowska… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: Chemokines are cytokines involved not only in inflammatory but also in
inappropriate response of the immune system in breast cancer (BC) progression. We …

The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s

A Potega, E Dabrowska, M Niemira, A Kot-Wasik… - Drug metabolism and …, 2011 - ASPET
5-Diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) is an antitumor agent that
is also active against autoimmune diseases. The intention of the present studies was to …

[HTML][HTML] Plasma level of MMP-10 may be a prognostic marker in early stages of breast cancer

BM Piskór, A Przylipiak, E Dąbrowska… - Journal of Clinical …, 2020 - mdpi.com
Background: Stromelysins are potential breast cancer biomarkers. The aim of the study was
to evaluate if plasma levels of selected metalloproteinases (MMPs) (stromelysin-1 (MMP-3) …

[CITATION][C] CC motif chemokine ligand 5 and CC chemokine receptor type 5: possible diagnostic application in breast cancer patients

E Dąbrowska, A Przylipiak, M Zajkowska… - Acta Biochimica …, 2020 - ojs.ptbioch.edu.pl
The chemokine CCL5 and its receptor CCR5 play important roles in cancer invasion and
metastasis. Based on our knowledge, our results were the first that presented the diagnostic …

A Novel Biomanufacturing System to Produce Multi-Material Scaffolds for Tissue Engineering: Concept and Preliminary Results

T Viana, S Biscaia, E Dabrowska… - Applied Mechanics …, 2019 - Trans Tech Publ
To produce multi-material scaffolds for Tissue Engineering accurate techniques are needed
in order to obtain three-dimensional constructs with clinically appropriate size and structural …

Plasma Matrilysins MMP-7 and MMP-26 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients

BM Piskór, A Przylipiak, E Dąbrowska, I Sidorkiewicz… - 2020 - researchsquare.com
Background: Metalloproteinases (MMPs) are a group of proteolytic enzymes involved in the
maintenance of a proper structure of extracellular matrix (ECM). Matrilysins (MMP-7 and …

Preparedness for Severe Maternal Morbidity in European Hospitals: The MaCriCare Study

P Krawczyk, D Dabrowska, E Guasch, H Jörnvall… - … Critical Care & Pain …, 2024 - Elsevier
Purpose To evaluate obstetric units (OUs) and intensive care units (ICUs) preparedness for
severe maternal morbidity (SMM). Methods From September 2021 to January 2022, an …